The human microbiome market is set to reach US$ 1,990.5 Mn by 2029 from US$ 840.1 Mn in 2020 at a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2021 to 2029. According to the research findings of World Health Organization (WHO), the burden associated with non-communicable diseases is set increase to 57% by 2020. The mortality rate related to chronic diseases will be more pronounced in the developing regions in comparison to the developed regions.
The major factors related to gastrointestinal disorders related to dietary problems are stress, low dietary intake, taking antacids frequently, sedentary lifestyle and craving for junk food etc. As mentioned in Lancet Research Journal 2019, chronic diseases such as diabetes, cardiovascular diseases, ulcerative colitis and even cancer can be prevented by maintaining healthy lifestyle and healthy dietary intake rich in probiotics, prebiotics and micronutrients.
"Prebiotics and probiotics are the largest product segment owing to its therapeutic efficacy"
Probiotics are healthy microorganism which aid in fighting against impending gastrointestinal diseases. They have been found beneficial in building the immune defense mechanism. The rich source of probiotics are dairy products especially yoghurt. Prebiotics are basically food for probiotics, they are fiber in nature which are consumed by probiotics in the intestinal tract releasing essential short chain fatty acids, essential amino acids etc. The rich sources of prebiotics are chicory root, Jerusalem artichoke, dandelion greens, garlic, leeks, onions etc. Probiotics and prebiotics are dominating the market due to rising prevalence of gastrointestinal disorders and increasing public health awareness. Supplements are gaining prominence on account of developing nutraceutical industry and growing importance of micronutrients in daily dietary intake.
"Growing importance of gut microflora in diagnosing gastrointestinal disorders propel the human microbiome market"
In the last two decades diligent research activities conducted in the nutraceutical and medical food industries has proven the therapeutic importance of human microbiota. There are millions of microbial gut flora which are either symbiotic or pathogenic in nature are present in the human intestine. Symbionts are very helpful in the digestion and absorption of nutrients, synthesis of certain amino acids and aid in building the immune system. Probiotics mimic these helpful microbial gut flora to maintain proper homeostasis of the human health. Researchers throughout the globe have concluded that microbes finding safe harbor in the human gut habitat can be harnessed to detect diseases ranging from acute infection to chronic inflammatory conditions.
"Rising prevalence of gastrointestinal disorders and established healthcare R&D segment drives the North America market"
In the present scenario North America is the clear leader in human microbiome market on account of the rising prevalence of gastrointestinal disorders and unhealthy eating and sedentary lifestyle. C.difficile infection, enterocolitis and diarrhea are the most occurring infectious intestinal diseases in North America. There is burgeoning requirement of probiotics to balance the microbial gut flora. In Europe the human microbiome market is driven by establishment of well-developed nutraceutical industry pioneering in prebiotics, probiotics and medical food. Asia Pacific is set to register excellent growth during the forecast period owing to key parameters such as increasing urbanization causing slums with poor civic amenities and lack of sanitation leading to intestinal diseases. In South East Asia infants suffer severely with cholera and diarrhea due to polluted drinking water. Asia Pacific serves as a lucrative market for medical food and supplement for the infants.
Market estimation and compounded annual growth rate were determined for human microbiome market by performing in depth analysis of the organic and inorganic growth strategies. Latest technological developments and recent trends prevailing in the human microbiome market are discussed thoroughly in the report. Patient compliance and their buying patterns related to supplements and medicinal food are thoroughly discussed in the report. Competitive landscape is covered to study the existing competitive nature among the major players of human microbiome market. Diverse varieties of food products are covered in the product portfolio segment. The major players providing human microbiomes are DuPont, Enterome Bioscience, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Synthetic Biologics, Inc., Synlogic, Inc., Vedanta Biosciences, Inc., Vithera Pharmaceuticals and Yakult Honsha Co., Ltd.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Human Microbiome market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Region Segment (2020–2030; US$ Million)
Global Impact of Covid-19 Segment (2020-2021; US$ Million )
Key questions answered in this report